Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 31, Issue 10, Pages 1845-1854
Publisher
Wiley
Online
2016-05-11
DOI
10.1002/jbmr.2870
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medical Treatment for Tumoral Calcinosis with Eight Years of Follow-up: A Report of Four Cases
- (2016) Ali Zein et al. Journal of Orthopaedic Surgery
- Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization
- (2015) L. Masi et al. CALCIFIED TISSUE INTERNATIONAL
- Hyperphosphatemic familial tumoral calcinosis: Response to acetazolamide and postulated mechanisms
- (2014) Gal Finer et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Rare Bone Diseases and Their Dental, Oral, and Craniofacial Manifestations
- (2014) B.L. Foster et al. JOURNAL OF DENTAL RESEARCH
- Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing
- (2014) Anuja Shah et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tumoral Calcinosis—A Pathogenetic Overview
- (2012) Richard E. Slavin et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Mechanism of FGF23 processing in fibrous dysplasia
- (2012) Nisan Bhattacharyya et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Fibroblast growth factor 23: state of the field and future directions
- (2012) Nisan Bhattacharyya et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Tumor-induced osteomalacia
- (2011) William H Chong et al. ENDOCRINE-RELATED CANCER
- Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
- (2011) Alan Yancovitch et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Revised Reference Curves for Bone Mineral Content and Areal Bone Mineral Density According to Age and Sex for Black and Non-Black Children: Results of the Bone Mineral Density in Childhood Study
- (2011) Babette S. Zemel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical variability of familial tumoral calcinosis caused by novelGALNT3mutations
- (2010) Shoji Ichikawa et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Familial Tumoral Calcinosis Caused by a Novel FGF23 Mutation: Response to Induction of Tubular Renal Acidosis with Acetazolamide and the Non-Calcium Phosphate Binder Sevelamer
- (2009) Juan Javier Lammoglia et al. HORMONE RESEARCH
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A case of familial tumoral calcinosis/hyperostosis–hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features
- (2008) C. E. Dumitrescu et al. OSTEOPOROSIS INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now